Pausing certain arthritis drugs after COVID-19 vaccination raises flare risk without improving antibody response
For patients with inflammatory arthritis, holding certain disease-modifying antirheumatic drugs (DMARDs), namely select biologic or Janus kinase inhibitor (JAKi) therapies, for two weeks at the time of a supplemental COVID-19 vaccine dose does not enhance humoral immunogenicity, according to a study published online Oct. 5 in JAMA Internal Medicine.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Abnormal lymph vessels show heightened growth signaling regardless of key gene mutation
United Kingdom
-
HIV treatment has transformed lives in the UK, but stigma lingers
United Kingdom
-
Sickle cell pain may involve previously unrecognized biological pathways
United Kingdom
-
Early-onset menopause linked to increased symptoms of anxiety and depression
United Kingdom
-
PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer
United Kingdom
-
Physically intense work and health: A new index to assess the burden of job tasks
United Kingdom
-
UCLA researcher wins the 2026 Albany Prize for revolutionary cancer therapy discoveries
United Kingdom
-
New AI model detects heart transplant rejection without biopsies
United Kingdom